Preclinical evaluation of a novel allosteric IL-1R inhibitor (rytvela) for the prevention of perinatal inflammation-induced fetal injury

  • Keelan, Jeffrey A (Primary Chief Investigator (PCI))
  • Olson, David M (Chief Investigator (CI))
  • Robertson, Sarah (Chief Investigator (CI))
  • Kemp, Matthew W (Chief Investigator (CI))
  • Dickinson, Hayley, (Chief Investigator (CI))
  • Ellery, Stacey (Chief Investigator (CI))

Project: Research

StatusActive
Effective start/end date1/01/1831/12/21

Funding

  • National Health & Medical Research Council (NHMRC): AUD1,377,827.40